Abstract:Objective To study the expression of cyclooxygenase-2 (COX-2) in the gastric epithelial carcinogensis and its relation with cell apoptosis and proliferation. Methods 15 cases of normal gastric mucosa (NGM), 30 cases of intestinal metaplasia (IM), 30 cases of dysplasia (Dys) and 40 cases of gastric cancer (GC) were used in this study. The expressions of COX-2 and proliferating cell nuclear antigen (PCNA) were detected by immunohistochemical SABC method, and cell apoptosis was measured by TUNEL. Results The expression level of COX-2 gradually increased from NGM, IM, Dys to GC. The positive rate of COX-2 in GC was 67.5%, 13.3% in NGM, and 33.3% in IM. There was a significant difference in COX-2 expression between GC and IM, GC and NGM(P0.05). Cell apoptosis index(AI) was 2.8±0.6 in GC. AI in GC was the lowest among all the pathological lesions (P0.01). Proliferation index (PI) from NGM, IM, Dys to GC also had an increasing tendency, and there were significant differences in PI between GC and the other precancerous lesions (P0.01). There was no significant difference in COX-2 expression among various precancerous lesions (P0.05). The expression of COX-2 in poorly differentiated cancer was markedly higher than that in well differentiated cancer (P0.05). The expression of both COX-2 and PI was closely correlated with the lymph node metastasis and vascular invasion of GC (P0.05). From NGM to IM, COX-2 expression level was positively correlated with AI (r=0.55,P0.05), but from Dys to GC, the negative correlation between COX-2 expression level and AI was observed (r=-0.56,P0.05). During gastric epithelial carcinogenesis, COX-2 expression was positively correlated with PI(r=0.61,P0.05). Conclusion COX-2 expression gradually increased during gastric epithelial carcinogenesis, and up-regulation of COX-2 may be an early event in this process. The expression level of COX-2 and PI may be helpful for evaluating the malignant degree metastasis and prognosis of GC. At the different stages of gastric carcinogenesis, COX-2 could stimulate cell proliferation, but at the early stages it promoted cell apoptosis, and inhibited cell apoptosis at the late stage.

The Value of Mg7-Ag and Cox-2 for Predicting Malignancy in Gastric Precancerous Lesions

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

Correlation and Significance of the Expressions of Cyclooxygenase-2 and Gastric Cancer-Associated Antigen MG7-Ag in Gastric Cancer and Non-Cancerous Tissue

[Association Between Promoter Methylation of Cyclooxygenase-2 and Expression, and Precancerous Gastric Lesions in a High-Risk Population].

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

The Clinical Significance and Expression of COX-2 and MMP-7 in Gastric Carcinoma

Expression of COX-2 in Different Subtypes of Gastric Intestinal Metaplasia and Gastric Carcinoma by T-issue Microarray

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Expression and Prognostic Value of MG7-Ag in Patients with Surgically Resectable Esophageal Squamous Cell Carcinoma

Role of CD97stalkand CD55 As Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients

Expression and clinical significance of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in gastric cancer

Value of C-Met for Predicting Progression of Precancerous Gastric Lesions in Rural Chinese Population.

The expreasion and its significance of COX-2 and MMP-2 in gastric carcinoma tissues

Correlation between the expression of COX-2 and VEGF in gastric cancer and their clinical significance

Expression of COX-2 in the Carcinogenesis of Gastric Epithelia and Its Correlation with Cell Apoptosis and Proliferation

[Expression of Cyclooxygenase-2 and Urokinase Plasminogen Activator in Gastric Carcinoma and the Clinical Significance Thereof].

Detection of Gastric Carcinoma-Associated Mg7-Ag by Serum Immuno-Pcr Assay in A High-Risk Chinese Population, with Implication for Screening

Correlation of expressions of COX-2 and VEGF with angiogenesis in gastric carcinoma

Expressions of COX-2 and VEGF-C in Gastric Cancer: Correlations with Lymphangiogenesis and Prognostic Implications

Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer

Significance of expression of COX-2 and GCS in gastric cancer